Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|January 1, 1995
Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumorsP J Houghton, P J Cheshire, J D Hallman, et al.International Journal of Cancer|April 15, 1994
Multiple mechanisms of resistance in a series of human testicular teratoma cell lines selected for increasing resistance to etoposideL K Hosking, R D Whelan, S A Shellard, et al.Cancer Research|August 17, 2000
Activation of CPT-11 in mice: identification and analysis of a highly effective plasma esteraseC L Morton, M Wierdl, L Oliver, et al.Medical and Pediatric Oncology|August 5, 2000
P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell linesA C Taylor, L Shu, M K Danks, et al.Cancer Research|April 18, 2001
Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expressionR V Iyengar, C A Pawlik, E J Krull, et al.Cytotechnology|January 1, 1993
Altered DNA topoisomerase II in multidrug resistanceW T Beck, M K Danks, J S Wolverton, et al.Molecular Pharmacology|November 6, 1998
Studies on the mechanism of resistance to rapamycin in human cancer cellsH Hosoi, M B Dilling, L N Liu, et al.Cancer Research|October 15, 1987
Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cellsW T Beck, M C Cirtain, M K Danks, et al.Cancer Chemotherapy and Pharmacology|March 11, 1999
Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell linesW C Zamboni, P J Houghton, J L Hulstein, et al.Cancer Research|June 30, 2001
A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11M M Meck, M Wierdl, L M Wagner, et al.Pageof 6